Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lipid A is a highly conserved glycolipid component that serves as the hydrophobic anchor of lipopolysaccharide (LPS) within the outer membrane of Gram-negative bacteria (Raetz & Whitfield, 2002). It is often referred to as endotoxin because it is the primary moiety responsible for the potent inflammatory response and toxic effects associated with Gram-negative infections via TLR4 activation (Beutler & Rietschel, 2003). Along with associated membrane phospholipids like phosphatidylethanolamine and phosphatidylglycerol, Lipid A maintains the structural integrity and selective permeability of the bacterial cell envelope (Nikaido, 2003). This target is clinically significant as the primary binding site for polymyxin antibiotics, such as colistin and polymyxin B (Poirel et al., 2017). These drugs interact electrostatically with the negatively charged phosphate groups of Lipid A, displacing stabilizing divalent cations and leading to membrane disruption and cell death (Trimble et al., 2016). However, modifications to Lipid A, such as the addition of 4-amino-4-deoxy-L-arabinose, represent a major mechanism of bacterial resistance (Baron et al., 2016).
Polymyxins bind to the negatively charged phosphate groups of lipid A and associated phospholipids through electrostatic interactions, displacing divalent cations (Mg2+ and Ca2+) that stabilize the outer membrane (StatPearls, 2023). This leads to increased membrane permeability, leakage of intracellular contents, and ultimately bacterial cell death (PubMed, PMID: 27337121).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial outer membrane lipid A and associated membrane phospholipids (Lipid A).